 |
 |

Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: The clinical trial of G-CSF therapy for patients with AMI by Dr Zohlnhöfer and colleagues1 showed that when compared with placebo, the therapy had no benefit in terms of infarct size and left ventricular function. Another trial also failed to show any functional improvement after AMI with G-CSF treatment.2 These results suggest that there might be some unknown mechanisms undermining the therapy.
A recent basic research study might provide an explanation for these results. Katayama et al3 found evidence that the sympathetic nervous system regulates hematopoietic stem cell mobilization in bone marrow. In their experiments, G-CSFinduced stem cell mobilization was stimulated by 2-adrenergic agonists but was suppressed by -blockers. These findings suggest that -blockers might have attenuated the effect of G-CSF in the patients studied by Zohlnhöfer et al by affecting the stem cell mobilization process. The authors reported that 100% of patients in the G-CSF group . . . [Full Text of this Article]
Jaewon Oh
drjaewonoh@gmail.com Yonsei University College of Medicine Seoul, Korea
Dae Hyun Kim, MD, MPH
Jefferson Medical College Philadelphia, Pa
Hyunseok Kang, MD
Yonsei University Graduate School of Public Health Seoul, Korea
RELATED ARTICLES
Granulocyte Colony-Stimulating Factor and Acute Myocardial Infarction
Wolf-Rüdiger Schäbitz, Sigrid Nikol, and Armin Schneider
JAMA. 2006;296(16):1967-1968.
EXTRACT
| FULL TEXT
Granulocyte Colony-Stimulating Factor and Acute Myocardial InfarctionReply
Dietlind Zohlnhöfer, Ilka Ott, Adnan Kastrati, and Albert Schömig
JAMA. 2006;296(16):1968-1969.
EXTRACT
| FULL TEXT
Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial
Dietlind Zohlnhöfer, Ilka Ott, Julinda Mehilli, Kathrin Schömig, Fabian Michalk, Tareq Ibrahim, Günther Meisetschläger, Jasper von Wedel, Hildegard Bollwein, Melchior Seyfarth, Josef Dirschinger, Claus Schmitt, Markus Schwaiger, Adnan Kastrati, Albert Schömig, and for the REVIVAL-2 Investigators
JAMA. 2006;295(9):1003-1010.
ABSTRACT
| FULL TEXT
|